Follow
Miguel Dario Prieto
Miguel Dario Prieto
Verified email at sfu.ca
Title
Cited by
Cited by
Year
Phenotypic and functional stability of leukocytes from human peripheral blood samples: considerations for the design of immunological studies
A Navas, L Giraldo-Parra, MD Prieto, J Cabrera, MA Gómez
BMC immunology 20, 1-8, 2019
222019
Biomarkers for the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis: a systematic review and meta-analysis
BCM Li, SM Huh, MD Prieto, G Hong, C Schwarz, RB Moss, BS Quon
The Journal of Allergy and Clinical Immunology: In Practice 9 (5), 1909-1930. e4, 2021
202021
Pharmacometabolomics of meglumine antimoniate in patients with cutaneous leishmaniasis
DA Vargas, MD Prieto, AJ Martínez-Valencia, A Cossio, KEV Burgess, ...
Frontiers in pharmacology 10, 657, 2019
172019
Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis
MD Prieto, ME Alam, AN Franciosi, BS Quon
ERJ Open Research 9 (1), 2023
102023
Case report: squamous cell carcinoma referred for Mohs surgery found to be cutaneous leishmaniasis
MD Prieto, AF Uribe-Restrepo, D Arcos, DA Vargas
The American Journal of Tropical Medicine and Hygiene 99 (6), 1537, 2018
102018
Eligibility for local therapies in adolescents and adults with cutaneous Leishmaniasis from southwestern Colombia: a cross-sectional study
AF Uribe-Restrepo, MD Prieto, A Cossio, MM Desai, M del Mar Castro
The American Journal of Tropical Medicine and Hygiene 100 (2), 306, 2019
92019
Comparative assessment of DNA targets and amplification methods for Leishmania (Viannia) detection in human samples
M Rosales-Chilama, N Diaz-Moreno, MD Prieto, L Giraldo-Parra, ...
The American journal of tropical medicine and hygiene 102 (6), 1323, 2020
52020
Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)
MA Gómez, A Navas, MD Prieto, L Giraldo-Parra, A Cossio, N Alexander, ...
Clinical Infectious Diseases 72 (10), e484-e492, 2021
42021
Inductively coupled plasma mass spectrometry method for plasma and intracellular antimony quantification applied to pharmacokinetics of meglumine antimoniate
DJ Garay-Baquero, DE Rebellón-Sánchez, MD Prieto, L Giraldo-Parra, ...
Bioanalysis 13 (8), 655-667, 2021
42021
Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease
MD Prieto, J Jang, AN Franciosi, Y Av-Gay, H Bach, SJ Tebbutt, BS Quon
Plos one 17 (12), e0278296, 2022
22022
Sensitivity and specificity of the remote evaluation of therapeutic response in cutaneous leishmaniasis using photographs from a mobile application
AM Del Castillo, M del Mar Castro, A Cossio, JAG Luna, D Rincón, ...
The American journal of tropical medicine and hygiene 107 (3), 662, 2022
22022
The diversity of clinical Mycobacterium abscessus isolates in morphology, glycopeptidolipids and infection rates in a macrophage model
V Pichler, L Dalkilic, G Shoaib, T Shapira, L Rankine-Wilson, ...
bioRxiv, 2024.02. 29.582856, 2024
2024
Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease
M Prieto, B Quon, J Jang, AN Franciosi, Y Av-Gay, H Bach, SJ Tebbutt
Methods 2023, 04-25, 2023
2023
Evaluation of host genetic susceptibility to predict nontuberculous mycobacteria pulmonary disease in patients with cystic fibrosis
MD Prieto Gaez
University of British Columbia, 2022
2022
Validated ICP-MS method for measurement of plasma and intracellular antimony concentrations applied to pharmacokinetics of meglumine antimoniate
DJ Garay-Baquero, DE Rebellon-Sánchez, MD Prieto, L Giraldo-Parra, ...
medRxiv, 2020.09. 15.20194647, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–15